| RS1572746634 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1572746651 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1572746998 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS1572747149 |
MSH6
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1572747278 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Hereditary nonpolyposis colon cancer |
| RS1572747685 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS1572747837 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 5 |
| RS1572748210 |
MSH6
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1572749758 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1572750549 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS1572750569 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS1572753822 |
FBXO11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS1572764698 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS1572764737 |
FBXO11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS1572770217 |
LPIN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoglobinuria, acute recurrent |
| RS1572776344 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS1572785471 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS1572785480 |
APOB
|
Health Risk |
Likely pathogenic |
Familial hypobetalipoproteinemia 1, Familial hypobetalipoproteinemia 1 |
| RS1572795820 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1572796197 |
PNPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 70, Autosomal recessive nonsyndromic hearing loss 70 |
| RS1572799173 |
APOB
|
Health Risk |
Likely pathogenic |
Familial hypobetalipoproteinemia 1, Familial hypobetalipoproteinemia 1 |
| RS1572800245 |
APOB
|
Health Risk |
Likely pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia 1 |
| RS1572801523 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1572802096 |
APOB
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1572804699 |
SLC3A1
|
Health Risk |
Likely pathogenic |
Cystine urolithiasis, Cystine urolithiasis |
| RS1572806589 |
FBXO11
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfanoid habitus and intellectual disability, Neurodevelopmental disorder |
| RS1572813576 |
NBAS
|
Health Risk |
Pathogenic |
Infantile liver failure syndrome 2, Infantile liver failure syndrome 2 |
| RS1572817589 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Leydig cell agenesis, Gonadotropin-independent familial sexual precocity |
| RS1572820988 |
FBXO11
|
Health Risk |
Likely pathogenic |
Obesity, Obesity |
| RS1572825920 |
PCARE
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 54 |
| RS1572826522 |
PCARE
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1572827477 |
PCARE
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 54 |
| RS1572829010 |
PCARE
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 54, Retinitis pigmentosa 54 |
| RS1572829514 |
PCARE
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1572829866 |
PCARE
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, PCARE-related retinopathy |
| RS1572830219 |
SOS1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 1, Noonan syndrome 1 |
| RS1572830513 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS1572830693 |
SOS1
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS1572834021 |
PNPT1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1572849873 |
TTC7A
|
Health Risk |
Pathogenic |
Multiple gastrointestinal atresias, Multiple gastrointestinal atresias |
| RS1572850869 |
EFEMP1
|
Health Risk |
Pathogenic |
14 conditions, Cutis laxa |
| RS1572874955 |
LHCGR
|
Health Risk |
Likely pathogenic |
Leydig cell agenesis, Leydig cell agenesis |
| RS1572875669 |
FAM161A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1572879569 |
FAM161A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS1572894174 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS1572894465 |
LRPPRC
|
Health Risk |
Likely pathogenic |
— |
| RS1572897958 |
ADAM17
|
Health Risk |
Pathogenic |
Inflammatory skin and bowel disease, neonatal |
| RS1572903776 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS1572907400 |
TET3
|
Health Risk |
Pathogenic/Likely pathogenic |
Beck-Fahrner syndrome, TET3 deficiency |
| RS1572907595 |
TET3
|
Health Risk |
Pathogenic/Likely pathogenic |
Beck-Fahrner syndrome, TET3 deficiency |
| RS1572911143 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572914269 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572914641 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572919267 |
ATP6V1B1
|
Health Risk |
Pathogenic |
Nephrocalcinosis, Polydactyly |
| RS1572922954 |
ATP6V1B1
|
Health Risk |
Likely pathogenic |
— |
| RS1572924733 |
ATP6V1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular acidosis with progressive nerve deafness, Renal tubular acidosis with progressive nerve deafness |
| RS1572931008 |
LPIN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoglobinuria, acute recurrent |
| RS1572931120 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572931360 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572932377 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572932845 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572933082 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572933385 |
ALMS1
|
Health Risk |
Pathogenic |
— |
| RS1572934951 |
ALMS1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1572935708 |
ALMS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572936092 |
ALMS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572936360 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572936972 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572937636 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572938044 |
SLC1A4
|
Health Risk |
Pathogenic |
— |
| RS1572939837 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572950925 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1572952530 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1572961263 |
TTC7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Common variable immunodeficiency, Multiple gastrointestinal atresias |
| RS1572967548 |
BCL11A
|
Health Risk |
Pathogenic |
— |
| RS1572969491 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1572970207 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alstrom syndrome |
| RS1572970628 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1572971860 |
SLC1A4
|
Health Risk |
Likely pathogenic |
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome, Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome |
| RS1572994572 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1572996700 |
EIF2AK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental regression, Global developmental delay |
| RS1573000963 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1573000972 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1573008071 |
NBAS
|
Health Risk |
Likely pathogenic |
Infantile liver failure syndrome 2, Short stature-optic atrophy-Pelger-Huët anomaly syndrome |
| RS1573009747 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1573010519 |
EIF2AK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cognitive impairment, Leukoencephalopathy |
| RS1573020369 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1573026975 |
CFH
|
Health Risk |
Pathogenic, low penetrance |
Hemolytic uremic syndrome, atypical |
| RS1573028017 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia |
| RS1573030204 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1573052379 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1573053394 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1573053412 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1573060017 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy |
| RS1573068097 |
TTC7A
|
Health Risk |
Likely pathogenic |
— |
| RS1573068995 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573072864 |
SPAST
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1573076111 |
CFH
|
Health Risk |
Pathogenic |
Hemolytic uremic syndrome, atypical |
| RS1573084845 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1573087200 |
CFH
|
Health Risk |
Likely pathogenic |
Hemolytic uremic syndrome, atypical |